
GSK-WI
US listing
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jul 27, 2022 | Before the open | 0.73 | 0.87 | +19.2% |
| Apr 29, 2022 | After the close | 0.93 | 1.09 | +17.2% |
| Feb 9, 2022 | Before the open | 0.81 | 0.86 | +6.2% |
| Oct 27, 2021 | Before the open | 1.01 | 1.26 | +24.8% |
| Jul 28, 2021 | Before the open | 0.64 | 0.98 | +53.1% |
| Apr 28, 2021 | Before the open | 0.76 | 0.79 | +3.9% |
| Feb 3, 2021 | Before the open | 0.80 | 0.77 | -3.8% |
| Oct 28, 2020 | Before the open | 1.00 | 1.25 | +25.0% |
| Jul 29, 2020 | Before the open | 0.64 | 0.57 | -10.9% |
| Apr 29, 2020 | Before the open | 0.71 | 0.96 | +35.2% |
| Feb 5, 2020 | Before the open | 0.67 | 0.64 | -4.5% |
| Oct 30, 2019 | Before the open | 0.85 | 0.95 | +11.8% |
| Jul 24, 2019 | Before the open | 0.62 | 0.79 |
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers…
| +27.4% |
| May 1, 2019 | Before the open | 0.65 | 0.78 | +20.0% |
| Feb 6, 2019 | Before the open | 0.67 | 0.81 | +20.9% |
| Oct 31, 2018 | Before the open | 0.88 | 0.92 | +4.5% |
| Jul 25, 2018 | Before the open | 0.78 | 0.79 | +1.3% |
| Apr 25, 2018 | After the close | 0.69 | 0.69 | 0.0% |
| Feb 7, 2018 | Before the open | 0.67 | 0.71 | +6.0% |